1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with naltrexone in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (naltrexone) | Trials (naltrexone) | Recent Studies (post-2010) (naltrexone) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 8,745 | 1,228 | 2,642 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | naltrexone (IC50) |
---|---|---|---|
Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0051 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0063 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.006 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.006 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0319 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0093 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.0377 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.0076 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chin, PY; Diener, KR; Hutchinson, MR; Moldenhauer, LM; Rice, KC; Robertson, SA; Sharkey, DJ; Wahid, HH | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and naltrexone
Article | Year |
---|---|
Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in Mice.
Topics: Animals; Female; Mice; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Obstetric Labor, Premature; Platelet Activating Factor; Pregnancy; Toll-Like Receptor 4 | 2020 |